Lack of evidence for use of glatiramer acetate in multiple sclerosis

This publication has 6 references indexed in Scilit:

• Interferons in relapsing remitting multiple sclerosis: a systematic review
  The Lancet, 2003
• European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis
  Annals of Neurology, 2001
• Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
  Neurology, 1995
• A placebo‐controlled, double‐blind, randomized, two‐center, pilot trial of Cop 1 in chronic progressive multiple sclerosis
  Neurology, 1991
• Surrogate endpoints in clinical trials: Definition and operational criteria
  Statistics in Medicine, 1989
• A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis
  New England Journal of Medicine, 1987